Onconetix Gets Nasdaq Notice For Late Quarterly Filing
12 Dec 2024 //
GLOBENEWSWIRE
Onconetix Gets $2M Series C And $25M Credit Line Via Private Sale
03 Oct 2024 //
GLOBENEWSWIRE
Onconetix Gets $2M Series C And $25M Credit Via Private Placement
03 Oct 2024 //
GLOBENEWSWIRE
Onconetix Announces Reverse Split And Meeting Results
20 Sep 2024 //
GLOBENEWSWIRE
Onconetix Announces Closing of Warrant Exercise for $1.11 Million Gross Proceeds
15 Jul 2024 //
GLOBENEWSWIRE
Onconetix Announces Exercise of Warrants for $1.11 Million Gross Proceeds
11 Jul 2024 //
GLOBENEWSWIRE
Onconetix Announces Appointment of Seasoned Biotech Executives
13 Feb 2024 //
GLOBENEWSWIRE